Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:43 PM
Ignite Modification Date:
2025-12-24 @ 7:43 PM
NCT ID:
NCT06789003
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years old.
* CML patient in chronic phase, eligible for oral therapy.
* Diagnosis of multiple myeloma.
* Patient eligible for autologous stem cell transplantation.
* Patient capable to read, understand and complete a questionnaire in french.
* WHO less than or equal to 2.
* Patient affiliated with french social security.
* Patient with a medical prescription for APA.
Exclusion Criteria:
* Patient with previous cancer within the previous 3 years (except basal cell and squamous cell skin cancers, carcinomas in situ of any type that have been previously resected, and stable prostate or breast cancers more than 3 years old and undergoing adjuvant hormone therapy).
* Medical contraindications to APA (heart failure, angina, unbalanced hypertension, bone metastases, severe osteoporosis, etc.)
* Sensory or motor neuropathy.
* Patient deprived of liberty, under guardianship or curatorship.
* Patient considered socially or psychologically unfit to be enrolled in a study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06789003
Study Brief:
Protocol Section:
NCT06789003